欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/1100/001
药品名称Cefotaxime-Swyssi
活性成分
    • cefotaxime sodium salt 1.0 g
剂型Powder for solution for injection
上市许可持有人Swyssi AG, Lyoner Strasse 14, Schwanheim Frankfurt am Main, 60528, Germany
参考成员国 - 产品名称Czechia (CZ)
Cefotaxime Swyssi
互认成员国 - 产品名称
    • Austria (AT)
    • Greece (GR)
    • Hungary (HU)
    • Romania (RO)
    • Slovakia (SK)
    • Croatia (HR)
许可日期2024/07/24
最近更新日期2024/07/24
药物ATC编码
    • J01DD01 cefotaxime
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase